Aug 20, 2025
Life Molecular Imaging Expands Neuraceq® (florbetaben F-18 injection) Production in Southern California
Jun 12, 2025
European Commission Grants Orphan Drug Designation to Florbetaben (18F) for Diagnosis of ATTR Amyloidosis
May 20, 2025
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Albany, NY
May 20, 2025
Life Molecular Imaging Secures Funding from the Alzheimer's Drug Discovery Foundation (ADDF) to Further Investigate [18F]F-DED PET in Alzheimer's Neuroinflammation
Apr 24, 2025
Life Molecular Imaging announces Neuraceq® availability at PharmaLogic Salt Lake City
Jan 21, 2025
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
Jan 06, 2025
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Somerset, NJ
Oct 29, 2024
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Cincinnati, OH
Aug 28, 2024
Life Molecular Imaging Receives FDA Fast Track Designation for [18F]PI-2620 in Tau PET Imaging Across Three Neurodegenerative Conditions
Aug 20, 2024
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver
Apr 05, 2024
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
Apr 05, 2024
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
Feb 06, 2024
Life Molecular Imaging and Oryx Isotopes Industrial Company announce a Strategic Partnership for the Production and Distribution of Florbetaben (18F) in the Kingdom of Saudi Arabia and other countries in reach
Jan 09, 2024
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Houston
Jan 15, 2020
Life Molecular Imaging announces presentation of new scientific data at the Human Amyloid Imaging Meeting
Oct 14, 2019
Life Molecular Imaging and Positron Pharma announce a strategic partnership for manufacturing and distribution of PI-2620 in Chile
Sep 17, 2019
Life Molecular Imaging started recruitment for longitudinal Phase 2 study with the Tau tracer PI-2620
Jun 14, 2019
Life Molecular Imaging and National Cyclotron and PET Centre, Chulabhorn Royal Academy, Thailand Announce a Collaboration for Brain PET Imaging with NeuraCeq and PI-2620
Apr 26, 2019
Life Molecular Imaging and Institut de Radiofarmàcia Aplicada de Barcelona (IRAB) Announce a Strategic Partnership for Production of NeuraCeq and PI-2620 in Barcelona
Apr 08, 2019
Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results